J5 peptide is an MBP inhibitor that competitively inhibits the binding of MBP85-99 to HLA-DR2. J5 peptide alleviates PLP139-151/MBP85-99-induced experimental autoimmune encephalomyelitis (EAE) in mice. J5 peptide can be used in research on inflammatory and immune diseases[1].
Molecular Weight:
1543.76
CAS Number:
[444305-16-2]
Formula:
C70H114N18O21
Target:
Biochemical Assay Reagents
Application Notes:
MCE Product type: Peptides
* VAT and and shipping costs not included. Errors and price changes excepted